AFT Pharmaceuticals Limited logo

Transition to new NZX listing rules wef 1 April 2019

NZX Compliance17 March 2019AFTHealthcare

Market release
18 March 2019


Transition to new NZX listing rules wef 1 April 2019


AFT Pharmaceuticals advises that with effect from 1 April 2019 it intends to comply with the

new NZX Listing Rules dated 1 January 2019.


[End of Release]


For more information:


Malcolm Tubby,

CFO, AFT Pharmaceuticals Ltd

Phone: +64 9 488 0232

Email: malcolm@aftpharm.com

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.